Marshall Wace
RVMD icon

Marshall Wace’s Revolution Medicines RVMD Stock Holding History

Marshall Wace’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.8M Buy
244,544
+27,883
+13% +$4.07M 0.04% 409
2026
Q1 		$21.1M Sell
216,661
-169,530
-44% -$17.1M 0.02% 688
2025
Q4 		$30.8M Buy
386,191
+225,095
+140% +$14.8M 0.03% 486
2025
Q3 		$7.52M Buy
161,096
+133,415
+482% +$5.22M 0.01% 1028
2025
Q2 		$1.02M Sell
27,681
-159,507
-85% -$6.13M ﹤0.01% 1838
2025
Q1 		$6.62M Sell
187,188
-1,317,613
-88% -$53.5M 0.01% 940
2024
Q4 		$65.8M Buy
1,504,801
+439,802
+41% +$22.2M 0.08% 226
2024
Q3 		$48.3M Buy
1,064,999
+248,944
+31% +$10.8M 0.06% 289
2024
Q2 		$31.7M Sell
816,055
-719,885
-47% -$26.9M 0.04% 363
2024
Q1 		$49.5M Buy
1,535,940
+327,011
+27% +$9.69M 0.08% 259
2023
Q4 		$34.7M Buy
1,208,929
+1,122,841
+1,304% +$27M 0.06% 321
2023
Q3 		$2.38M Buy
+86,088
New +$2.55M ﹤0.01% 1147
2022
Q2 		– Sell
-157,005
Closed -$4.01M – 3788
2022
Q1 		$4.01M Buy
157,005
+155,976
+15,158% +$3.39M 0.01% 1547
2021
Q4 		$26K Buy
+1,029
New +$29K ﹤0.01% 3679
2021
Q3 		– Sell
-35,031
Closed -$1.11M – 3369
2021
Q2 		$1.11M Buy
+35,031
New +$1.22M 0.01% 1760

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Marshall Wace's RVMD Position: Q2 2026 in Review

Marshall Wace increased its Revolution Medicines (RVMD) stake by 13% in Q2 2026, buying an estimated $4.07M and bringing the position to 244,544 shares worth $45.8M. The position accounts for 0.04% of the portfolio, ranked #409.

Marshall Wace first reported a position in RVMD in Q2 2021 and has held it in 15 quarters since. The position peaked at $65.8M in Q4 2024. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Marshall Wace held 244,544 shares of Revolution Medicines worth $45.8M as of Q2 2026.
  • Marshall Wace bought 27,883 Revolution Medicines shares in Q2 2026, an estimated $4.07M.
  • Revolution Medicines made up 0.04% of Marshall Wace's portfolio in Q2 2026, its #409 holding.
  • Marshall Wace first reported a position in Revolution Medicines in Q2 2021 and has held it in 15 quarters since.
  • Marshall Wace's Revolution Medicines position peaked at $65.8M in Q4 2024.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.